Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the United States: A Systematic Review

Abstract

Significant support exists in the United States for legalization of marijuana/cannabis. As of 2021, 36 states and four territories approved the legalization of medical cannabis via medical marijuana laws (MMLs), and 15 states and District of Columbia (DC) have adopted recreational marijuana laws (RMLs). We performed structured and systematic searches of articles published from 2010 through September 2021. We assess the literature pertaining to adolescent marijuana use; opioid use and opioid-related outcomes; alcohol use; tobacco use; illicit and other drug use; marijuana growing and cultivation; employment, earnings, and other workplace outcomes; academic achievement and performance; criminal activity; perceived harmfulness; traffic and road safety; and suicide and sexual activity. Overall, 113 articles satisfied our inclusion criteria. Except for opioids, studies on use of other substances (illicit drugs, tobacco, and alcohol) were inconclusive. MMLs and RMLs do not generate negative outcomes in the labor market, lead to greater criminal activity, or reduce traffic and road safety.

Keywords

marijuana medical recreational policies laws costs outcomes

Get full access to this article

View all access options for this article.

References

Abouk

Adams

(2018). Examining the relationship between medical cannabis laws and cardiovascular deaths in the U.S. International Journal of Drug Policy, 53, 1–7. https://doi.org/10.1016/j.drugpo.2017.11.022

Abouk

Ghimire

K. M.

Maclean

J. C.

Powell

(2021). Does marijuana legalization affect work capacity? Evidence from workers’ compensation benefits [NBER Working Paper Series]. https://www.nber.org/papers/w28471

Alcocer

J. J.

(2020). Exploring the effect of Colorado’s recreational marijuana policy on opioid overdose rates. Public Health, 185, 8–14. https://doi.org/10.1016/j.puhe.2020.04.007

Ali

M. M.

McClellan

West

K. D.

Mutter

(2021). Medical marijuana laws, marijuana use, and opioid-related outcomes among women in the United States [Article]. Women’s Health Issues, 31(1), 24–30. https://doi.org/10.1016/j.whi.2020.09.003

Ali

M. M.

McClellan

C. B.

Mutter

Rees

D. I.

(2021). Recreational marijuana laws and the use of opioids: Evidence from NSDUH microdata [NBER Working Paper Series]. https://www.nber.org/papers/w29087

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

American Public Health Association. (2014). Regulating commercially legalized marijuana as a public health priority. https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2015/01/23/10/17/regulating-commercially-legalized-marijuana-as-a-public-health-priority

Anderson

D. M.

Hansen

Rees

D. I.

(2013). Medical marijuana laws, traffic fatalities, and alcohol consumption. Journal of Law and Economics, 56(2), 333–369. https://doi.org/10.1086/668812

Anderson

D. M.

Hansen

Rees

D. I.

(2015). Medical marijuana laws and teen marijuana use. American Law and Economics Review, 17(2), 495–528. https://doi.org/10.1093/aler/ahv002

10.

Anderson

D. M.

Hansen

Rees

D. I.

Sabia

J. J.

(2019). Association of marijuana laws with teen marijuana use: New estimates from the youth risk behavior surveys. JAMA Pediatrics, 173(9), 879–881.

11.

Anderson

D. M.

Rees

D. I.

Sabia

J. J.

(2014). Medical marijuana laws and suicides by gender and age. American Journal of Public Health, 104(12), 2369–2376. https://doi.org/10.2105/AJPH.2013.301612

12.

Anderson

D. M.

Rees

D. I.

Tekin

(2018). Medical marijuana laws and workplace fatalities in the United States. International Journal of Drug Policy, 60, 33–39. https://doi.org/10.1016/j.drugpo.2018.07.008

13.

Aydelotte

J. D.

Brown

L. H.

Luftman

K. M.

Mardock

A. L.

Teixeira

P. G. R.

Coopwood

Brown

C. V. R.

(2017). Crash fatality rates after recreational marijuana legalization in Washington and Colorado. American Journal of Public Health, 107(8), 1329–1331. https://doi.org/10.2105/AJPH.2017.303848

14.

Bachhuber

M. A.

Saloner

Cunningham

C. O.

Barry

C. L.

(2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668–1673. https://doi.org/10.1001/jamainternmed.2014.4005

15.

Baggio

Chong

Simon

(2020). Sex, marijuana and baby booms. Journal of Health Economics, 70, 102283. https://doi.org/10.1016/j.jhealeco.2019.102283

16.

Benedetti

M. H.

Neuroth

L. M.

Humphries

K. D.

Brooks-Russell

Zhu

(2021a). Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: An analysis of the 2013–2017 Traffic Safety Culture Index. BMC Research Notes, 14(1), 226. https://doi.org/10.1186/s13104-021-05643-3

17.

Benedetti

M. H.

Neuroth

L. M.

Humphries

K. D.

Brooks-Russell

Zhu

(2021b). Self-reported driving after marijuana use in association with medical and recreational marijuana policies. International Journal of Drug Policy, 92, 102944. https://doi.org/10.1016/j.drugpo.2020.102944

18.

Blevins

C. E.

Marsh

Banes

K. E.

Stephens

R. S.

Walker

D. D.

Roffman

R. A.

(2018). The implications of cannabis policy changes in Washington on adolescent perception of risk, norms, attitudes, and substance use. Substance Abuse: Research and Treatment, 12. https://doi.org/10.1177/1178221818815491

19.

Boehnke

K. F.

Litinas

Clauw

D. J.

(2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. Journal of Pain, 17(6), 739–744. https://doi.org/10.1016/j.jpain.2016.03.002

20.

Bradford

A. C.

Bradford

W. D.

(2016). Medical marijuana laws reduce prescription medication use in Medicare Part D. Health Affairs, 35(7), 1230–1236. https://doi.org/10.1377/hlthaff.2015.1661

21.

Bradford

A. C.

Bradford

W. D.

(2017). Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs, 36(5), 945–951. https://doi.org/10.1377/hlthaff.2016.1135

22.

Bradford

A. C.

Bradford

W. D.

(2018). The impact of medical cannabis legalization on prescription medication use and costs under Medicare Part D. Journal of Law and Economics, 61(3), 461–487. https://doi.org/10.1086/699620

23.

Bradford

A. C.

Bradford

W. D.

Abraham

Adams

G. B.

(2018). Association between U.S. state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Internal Medicine, 178(5), 667–673. https://doi.org/10.1001/jamainternmed.2018.0266

24.

Brenan

(2020). Support for legal marijuana inches up to new high of 68%. https://news.gallup.com/poll/323582/support-legal-marijuana-inches-new-high.aspx

25.

Brooks

Gundersen

D. C.

Flynn

Brooks-Russell

Bull

(2017). The clinical implications of legalizing marijuana: Are physician and non-physician providers prepared? Addictive Behaviors, 72, 1–7. https://doi.org/10.1016/j.addbeh.2017.03.007

26.

Brooks-Russell

Levinson

A. H.

Kattari

Kirchner

Anderson Goodell

E. M.

Johnson

R. M.

(2019). Adolescent marijuana use, marijuana-related perceptions, and use of other substances before and after initiation of retail marijuana sales in Colorado (2013–2015). Prevention Science, 20(2), 185–193. https://doi.org/10.1007/s11121-018-0933-2

27.

Caputi

T. L.

Humphreys

(2018). Medical marijuana users are more likely to use prescription drugs medically and nonmedically. Journal of Addiction Medicine, 12(4), 295–299. https://doi.org/10.1097/ADM.0000000000000405

28.

Cerdá

Sarvet

A. L.

Wall

Feng

Keyes

K. M.

Galea

Hasin

D. S.

(2018). Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs. Drug and Alcohol Dependence, 183, 62–68. https://doi.org/10.1016/j.drugalcdep.2017.10.021

29.

Cerdá

Wall

Feng

Keyes

K. M.

Sarvet

Schulenberg

O’Malley

P. M.

Pacula

R. L.

Galea

Hasin

D. S.

(2017). Association of state recreational marijuana laws with adolescent marijuana use. JAMA Pediatrics, 171(2), 142–149. https://doi.org/10.1001/jamapediatrics.2016.3624

30.

Chan

N. W.

Burkhardt

Flyr

(2020). The effects of recreational marijuana legalization and dispensing on opioid mortality. Economic Inquiry, 58(2), 589–606. https://doi.org/10.1111/ecin.12819

31.

Chen

Stanton

Cook

R. L.

Chen

D. G.

Okafor

(2018). Medical marijuana laws and marijuana use among U.S. adolescents: Evidence from Michigan youth risk behavior surveillance data. Journal of Drug Education, 48(1–2), 18–35. https://doi.org/10.1177/0047237918803361

32.

Choi

Dave

Sabia

J. J.

(2019). Smoke gets in your eyes: Medical marijuana laws and tobacco use. American Journal of Health Economics, 5(3), 303–333. https://doi.org/10.1162/ajhe

33.

Choo

E. K.

Benz

Zaller

Warren

Rising

K. L.

McConnell

K. J.

(2014). The impact of state medical marijuana legislation on adolescent marijuana use. Journal of Adolescent Health, 55(2), 160–166. https://doi.org/10.1016/j.jadohealth.2014.02.018

34.

Chu

Y. W. L.

(2015). Do medical marijuana laws increase hard-drug use? Journal of Law and Economics, 58(2), 481–517. https://doi.org/10.1086/684043

35.

Chu

Y. W. L.

Gershenson

(2018). High times: The effect of medical marijuana laws on student time use. Economics of Education Review, 66, 142–153. https://doi.org/10.1016/j.econedurev.2018.08.003

36.

Chu

Y. W. L.

Townsend

(2019). Joint culpability: The effects of medical marijuana laws on crime. Journal of Economic Behavior and Organization, 159, 502–525. https://doi.org/10.1016/j.jebo.2018.07.003

37.

Coley

R. L.

Hawkins

S. S.

Ghiani

Kruzik

Baum

C. F.

(2019). A quasi-experimental evaluation of marijuana policies and youth marijuana use. American Journal of Drug and Alcohol Abuse, 45(3), 292–303. https://doi.org/10.1080/00952990.2018.1559847

38.

Cook

A. C.

Leung

Smith

R. A.

(2020). Marijuana decriminalization, medical marijuana laws, and fatal traffic crashes in U.S. Cities, 2010-2017. American Journal of Public Health, 110(3), 363–369. https://doi.org/10.2105/AJPH.2019.305484

39.

Dills

A. K.

Goffard

Miron

(2017). The effects of marijuana liberalizations: Evidence from monitoring the future [NBER Working Paper Series 50]. https://doi.org/10.3386/w23779

40.

Dragone

Prarolo

Vanin

Zanella

(2019). Crime and the legalization of recreational marijuana. Journal of Economic Behavior and Organization, 159, 488–501.

41.

Ehrlich

Simpson

Busch Isaksen

(2020). Sociopolitical externalities impacting worker health in Washington State’s cannabis industry. Annals of Work Exposures and Health, 64(7), 683–692. https://doi.org/10.1093/annweh/wxz083

42.

Estoup

A. C.

Moise-Campbell

Varma

Stewart

D. G.

(2016). The impact of marijuana legalization on adolescent use, consequences, and perceived risk. Substance Use and Misuse, 51(14), 1881–1887. https://doi.org/10.1080/10826084.2016.1200623

43.

Feldmann

Armendáriz

Cone

Daly

(2020). The global commoditization of marijuana and hemp. The Brief, 49(4), 38–47.

44.

Fink

D. S.

Stohl

Sarvet

A. L.

Cerda

Keyes

K. M.

Hasin

D. S.

(2020). Medical marijuana laws and driving under the influence of marijuana and alcohol. Addiction, 115(10), 1944–1953. https://doi.org/10.1111/add.15031

45.

Flexon

J. L.

Stolzenberg

D’Alessio

S. J.

(2019). The effect of cannabis laws on opioid use. International Journal of Drug Policy, 74, 152–159. https://doi.org/10.1016/j.drugpo.2019.09.013

46.

Ford

Ludlum

(2013). Medical marijuana and employment discrimination. Southern Law Journal, 23, 289.

47.

Freisthler

Ponicki

W. R.

Gaidus

Gruenewald

P. J.

(2016). A micro-temporal geospatial analysis of medical marijuana dispensaries and crime in Long Beach, California. Addiction, 111(6), 1027–1035. https://doi.org/10.1111/add.13301

48.

Gavrilova

Kamada

Zoutman

(2019). Is legal pot crippling Mexican drug trafficking organisations? The effect of medical marijuana laws on U.S. crime. The Economic Journal, 129(617), 375–407. https://doi.org/10.1111/ecoj.12521

49.

Ghimire

K. M.

Maclean

J. C.

(2020). Medical marijuana and workers’ compensation claiming. Health Economics (United Kingdom), 29(4), 419–434. https://doi.org/10.1002/hec.3992

50.

Haffajee

Mauri

(2021). Cannabis liberalization in the U.S.: The policy landscape. Health Affairs Policy Brief. https://www.healthaffairs.org/do/10.1377/hpb20210518.36548/full/

51.

Hamzeie

Thompson

Roy

Savolainen

P. T.

(2017). State-level comparison of traffic fatality data in consideration of marijuana laws. Transportation Research Record, 2660(1), 78–85. https://doi.org/10.3141/2660-11

52.

Hansen

Miller

Weber

(2020). Early evidence on recreational marijuana legalization and traffic fatalities. Economic Inquiry, 58(2), 547–568. https://doi.org/10.1111/ecin.12751

53.

Hao

Cowan

B. W.

(2020). The cross-border spillover effects of recreational marijuana legislation. Economic Inquiry, 58(2), 642–666. https://doi.org/10.1111/ecin.12764

54.

Harris

K. D.

(2019). S.2227—116th Congress (2019-2020): MORE Act of 2019. https://www.congress.gov/bill/116th-congress/senate-bill/2227

55.

Hasin

D. S.

Saha

T. D.

Kerridge

B. T.

Goldstein

R. B.

Chou

S. P.

Zhang

Jung

Pickering

R. P.

Ruan

Smith

S. M.

Huang

Grant

B. F.

(2015). Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235–1242. https://doi.org/10.1001/jamapsychiatry.2015.1858

56.

Hasin

D. S.

Wall

Keyes

K. M.

Cerdá

Schulenberg

O’Malley

P. M.

Galea

Pacula

Feng

(2015). Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: Results from annual, repeated cross-sectional surveys. The Lancet Psychiatry, 2(7), 601–608. https://doi.org/10.1016/S2215-0366(15)00217-5

57.

Hsu

Kovács

(2021). Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: Panel data study. BMJ, 372, Article m4957. https://doi.org/10.1136/bmj.m4957

58.

Humphreys

Saitz

(2019). Should physicians recommend replacing opioids with cannabis? Journal of the American Medical Association, 321(7), 639–640. https://doi.org/10.7326/M17-0155

59.

Ishida

J. H.

Wong

P. O.

Cohen

B. E.

Vali

Steigerwald

Keyhani

(2019). Substitution of marijuana for opioids in a national survey of U.S. adults. PLOS ONE, 14(10), Article e0222577. https://doi.org/10.1371/journal.pone.0222577

60.

Jayawardhana

Fernandez

J. M.

(2021). The associations of medical marijuana policies with opioid-related health care utilization. Health Services Research, 56(2), 299–309. https://doi.org/10.1111/1475-6773.13632

61.

Johnson

J. K.

Hodgkin

Harris

S. K.

(2017). The design of medical marijuana laws and adolescent use and heavy use of marijuana: Analysis of 45 states from 1991 to 2011. Drug and Alcohol Dependence, 170, 1–8. https://doi.org/10.1016/j.drugalcdep.2016.10.028

62.

Johnson

J. K.

Johnson

R. M.

Hodgkin

Jones

A. A.

Matteucci

A. M.

Harris

S. K.

(2018). Heterogeneity of state medical marijuana laws and adolescent recent use of alcohol and marijuana: Analysis of 45 states, 1991–2011. Substance Abuse, 39(2), 247–254. https://doi.org/10.1080/08897077.2017.1389801

63.

Jones

J. M.

Shults

R. A.

Robinson

Komatsu

K. K.

Sauber-Schatz

E. K.

(2019). Marijuana and alcohol use among injured drivers evaluated at level I trauma centers in Arizona, 2008-2014. Drug and Alcohol Dependence, 204, 107539. https://doi.org/10.1016/j.drugalcdep.2019.06.041

64.

Kan

Beardslee

Frick

P. J.

Steinberg

Cauffman

(2020). Marijuana use among justice-involved youths after California statewide legalization, 2015-2018. American Journal of Public Health, 110(9), 1386–1392. https://doi.org/10.2105/AJPH.2020.305797

65.

Keyes

K. M.

Wall

Cerdá

Schulenberg

O’Malley

P. M.

Galea

Feng

Hasin

D. S.

(2016). How does state marijuana policy affect U.S. youth? Medical marijuana laws, marijuana use and perceived harmfulness: 1991–2014. Addiction, 111(12), 2187–2195. https://doi.org/10.1111/add.13523

66.

Kim

J. H.

Santaella-Tenorio

Mauro

Wrobel

Cerda

Keyes

K. M.

Hasin

Martins

S. S.

(2016). State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. American Journal of Public Health, 106(11), 2032–2037. https://doi.org/10.2105/AJPH.2016.303426

67.

Kim

J. H.

Weinberger

A. H.

Zhu

Barrington-Trimis

Wyka

Goodwin

R. D.

(2021). Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004–2017 [Article]. Drug and Alcohol Dependence, 218, 108364. https://doi.org/10.1016/j.drugalcdep.2020.108364

68.

Klassen

Anthony

B. P.

(2019). The effects of recreational cannabis legalization on forest management and conservation efforts in U.S. national forests in the Pacific Northwest. Ecological Economics, 162, 39–48. https://doi.org/10.1016/j.ecolecon.2019.04.029

69.

Lee

Y. H.

Chang

Y. C.

Liu

C. T.

Arndt

(2020). Is medical marijuana legalization associated with prescription drug misuse, illicit drug use, or combination of both among adults in the United States? Journal of Drug Issues, 50(4), 566–578. https://doi.org/10.1177/0022042620942152

70.

Lensch

Sloan

Ausmus

Pearson

J. L.

Clements-Nolle

Goodman

Hammond

(2020). Cannabis use and driving under the influence: Behaviors and attitudes by state-level legal sale of recreational cannabis [Article]. Preventive Medicine, 141, 106320. https://doi.org/10.1016/j.ypmed.2020.106320

71.

Liang

Bao

Wallace

Grant

Shi

(2018). Medical cannabis legalization and opioid prescriptions: Evidence on U.S. Medicaid enrollees during 1993–2014. Addiction, 113(11), 2060–2070. https://doi.org/10.1111/add.14382

72.

Livingston

M. D.

Barnett

T. E.

Delcher

Wagenaar

A. C.

(2017). Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. American Journal of Public Health, 107(11), 1827–1829. https://doi.org/10.2105/AJPH.2017.304059

73.

Lopez

A. K. K.

Nichols

S. D.

Chung

D. Y.

Kaufman

D. E.

McCall

K. L.

Piper

B. J.

(2020). Prescription opioid distribution after the legalization of recreational marijuana in Colorado. International Journal of Environmental Research and Public Health, 17(9), 3251. https://doi.org/10.3390/ijerph17093251

74.

Lopez

C. D.

Boddapati

Jobin

C. M.

Hickernell

T. R.

(2021). State medical cannabis laws associated with reduction in opioid prescriptions by orthopaedic surgeons in Medicare Part D cohort. The Journal of the American Academy of Orthopaedic Surgeons, 29(4), e188–e197. https://doi.org/10.5435/JAAOS-D-19-00767

75.

Lynne-Landsman

S. D.

Livingston

M. D.

Wagenaar

A. C.

(2013). Effects of state medical marijuana laws on adolescent marijuana use. American Journal of Public Health, 103(8), 1500–1506. https://doi.org/10.2105/AJPH.2012.301117

76.

Maclean

J. C.

Ghimire

K. M.

Nicholas

L. H.

(2017). Marijuana legalization and disability claiming [NBER Working Paper Series 23862]. https://doi.org/10.1002/hec.4190

77.

Maier

S. L.

Mannes

Koppenhofer

E. L.

(2017). The implications of marijuana decriminalization and legalization on crime in the United States. Contemporary Drug Problems, 44(2), 125–146. https://doi.org/10.1177/0091450917708790

78.

Mason

W. A.

Fleming

C. B.

Ringle

J. L.

Hanson

Gross

T. J.

Haggerty

K. P.

(2016). Prevalence of marijuana and other substance use before and after Washington state’s change from legal medical marijuana to legal medical and nonmedical marijuana: Cohort comparisons in a sample of adolescents. Substance Abuse, 37(2), 330–335. https://doi.org/10.1080/08897077.2015.1071723

79.

Masten

S. V.

Guenzburger

G. V.

(2014). Changes in driver cannabinoid prevalence in 12 U.S. states after implementing medical marijuana laws. Journal of Safety Research, 50, 35–52. https://doi.org/10.1016/j.jsr.2014.03.009

80.

Matthay

E. C.

Kiang

M. V.

Elser

Schmidt

Humphreys

(2021). Evaluation of state cannabis laws and rates of self-harm and assault. JAMA Network Open, 4(3), 1–14. https://doi.org/10.1001/jamanetworkopen.2021.1955

81.

Mauro

C. M.

Newswanger

Santaella-Tenorio

Mauro

P. M.

Carliner

Martins

S. S.

(2019). Impact of medical marijuana maws on state-level marijuana use by age and gender, 2004–2013. Prevention Science, 20(2), 205–214. https://doi.org/10.1007/s11121-017-0848-3

82.

McMichael

B. J.

Van Horn

R. L.

Viscusi

W. K.

(2020). The impact of cannabis access laws on opioid prescribing. Journal of Health Economics, 69, 102273. https://doi.org/10.1016/j.jhealeco.2019.102273

83.

Melchior

Nakamura

Bolze

Hausfater

El Khoury

Mary-Krause

Azevedo Da Silva

(2019). Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis. BMJ Open, 9(7), Article e025880. https://doi.org/10.1136/bmjopen-2018-025880

84.

Mennis

(2020). Trends in adolescent treatment admissions for marijuana in the United States, 2008-2017. Preventing Chronic Disease, 17, 200156. https://doi.org/10.5888/pcd17.200156

85.

Mennis

Stahler

G. J.

Mason

M. J.

(2021). Treatment admissions for opioids, cocaine, and methamphetamines among adolescents and emerging adults after legalization of recreational marijuana. Journal of Substance Abuse Treatment, 122, 108228. https://doi.org/10.1016/j.jsat.2020.108228

86.

Miech

R. A.

Johnston

O’Malley

P. M.

Bachman

J. G.

Schulenberg

Patrick

M. E.

(2015). Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: The case of California 2007-2013. International Journal of Drug Policy, 26(4), 336–344. https://doi.org/10.1016/j.drugpo.2015.01.009

87.

Morris

R. G.

TenEyck

Barnes

J. C.

Kovandzic

T. V.

(2014). The effect of medical marijuana laws on crime: Evidence from state panel data, 1990-2006. PLOS ONE, 9(3), Article e92816. https://doi.org/10.1371/journal.pone.0092816

88.

National Center for Complementary and Integrative Health. (2019). Cannabis (marijuana) and cannabinoids: What you need to know. https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

89.

National Conference of State Legislatures. (2021). State medical marijuana laws. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx

90.

National Institute on Drug Abuse. (2019). Marijuana drug facts. https://www.drugabuse.gov/publications/drugfacts/marijuana

91.

National Institute on Drug Abuse. (2021). Is there a link between marijuana use and psychiatric disorders? https://www.drugabuse.gov/publications/research-reports/marijuana/there-link-between-marijuana-use-psychiatric-disorders

92.

Neavyn

M. J.

Blohm

Babu

K. M.

Bird

S. B.

(2014). Medical marijuana and driving: A review. Journal of Medical Toxicology, 10(3), 269–279. https://doi.org/10.1007/s13181-014-0393-4

93.

Nicholas

L. H.

Maclean

J. C.

(2019). The effect of medical marijuana laws on the health and labor supply of older adults: Evidence from the health and retirement study. Journal of Policy Analysis and Management, 38(2), 455–480. https://doi.org/10.1002/pam.22122

94.

Nielsen

A. L.

(2010). Americans’ attitudes toward drug-related issues from 1975-2006: The roles of period and cohort effects. Journal of Drug Issues, 40(2), 461–494. https://doi.org/10.1177/002204261004000209

95.

Park

S. M.

Shen

J. J.

Yoo

J. W.

Reed

S. M.

(2020). The effect of marijuana legalization on the trajectories of hard drug–related hospitalizations: A growth curve analysis of the county-level State Inpatient Database in Washington, 2009–2015. Journal of Drug Issues, 50(3), 273–285. https://doi.org/10.1177/0022042620912695

96.

Parnes

J. E.

Smith

J. K.

Conner

B. T.

(2018). Reefer madness or much ado about nothing? Cannabis legalization outcomes among young adults in the United States. International Journal of Drug Policy, 56, 116–120. https://doi.org/10.1016/j.drugpo.2018.03.011

97.

Paschall

M. J.

García-Ramírez

Grube

J. W.

(2021). Recreational marijuana legalization and use among California adolescents: Findings from a statewide survey. Journal of Studies on Alcohol and Drugs, 82(1), 103–111. https://doi.org/10.15288/jsad.2021.82.103

98.

Paschall

M. J.

Grube

J. W.

(2020). Recreational marijuana availability in Oregon and use among adolescents. American Journal of Preventive Medicine, 58(2), e63–e69. https://doi.org/10.1016/j.amepre.2019.09.020

99.

Petrova

Gray

(2021). The effects of medical marijuana laws on birth outcomes: Evidence from early adopting U.S. states. Economic Analysis and Policy, 69, 68–82. https://doi.org/10.1016/j.eap.2020.11.004

100.

Plunk

A. D.

Agrawal

Harrell

P. T.

Tate

W. F.

Will

K. E.

Mellor

J. M.

Grucza

R. A.

(2016). The impact of adolescent exposure to medical marijuana laws on high school completion, college enrollment and college degree completion. Drug and Alcohol Dependence, 168, 320–327. https://doi.org/10.1016/j.drugalcdep.2016.09.002

101.

Powell

Pacula

R. L.

Jacobson

(2018). Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics, 58, 29–42. https://doi.org/10.1016/j.jhealeco.2017.12.007

102.

Prestemon

J. P.

Koch

F. H.

Donovan

G. H.

Lihou

M. T.

(2019). Cannabis legalization by states reduces illegal growing on U.S. national forests. Ecological Economics, 164, 106366. https://doi.org/10.1016/j.ecolecon.2019.106366

103.

Raji

M. A.

Abara

N. O.

Salameh

Westra

J. R.

Kuo

Y. F.

(2019). Association between cannabis laws and opioid prescriptions among privately insured adults in the U.S. Preventive Medicine, 125, 62–68. https://doi.org/10.1016/j.ypmed.2019.05.012

104.

Richter

Pugh

B. S.

Ball

S. A.

(2017). Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana. American Journal of Drug and Alcohol Abuse, 43(3), 247–260. https://doi.org/10.3109/00952990.2016.1164711

105.

Sabia

J. J.

Dave

D. M.

Alotaibi

Rees

D. I.

(2021). Is recreational marijuana a gateway to harder drug use and crime? [NBER Working Paper Series]. http://www.nber.org/papers/w29038

106.

Sabia

J. J.

Nguyen

T. T.

(2018). The effect of medical marijuana laws on labor market outcomes. Journal of Law and Economics, 61(3), 361. https://doi.org/10.1086/701193

107.

Santaella-Tenorio

Mauro

C. M.

Wall

M. M.

Kim

J. H.

Cerdá

Keyes

K. M.

Hasin

D. S.

Galea

Martins

S. S.

(2017). U.S. traffic fatalities, 1985-2014, and their relationship to medical marijuana laws. American Journal of Public Health, 107(2), 336–342. https://doi.org/10.2105/AJPH.2016.303577

108.

Santaella-Tenorio

Wheeler-Martin

Dimaggio

C. J.

Castillo-Carniglia

Keyes

K. M.

Hasin

Cerdá

(2020). Association of recreational cannabis laws in Colorado and Washington state with changes in traffic fatalities, 2005-2017. JAMA Internal Medicine, 180(8), 1061–1068. https://doi.org/10.1001/jamainternmed.2020.1757

109.

Sarvet

A. L.

Wall

M. M.

Keyes

K. M.

Cerdá

Schulenberg

J. E.

O’Malley

P. M.

Johnston

L. D.

Hasin

D. S.

(2018). Recent rapid decrease in adolescents’ perception that marijuana is harmful, but no concurrent increase in use. Drug and Alcohol Dependence, 186, 68–74. https://doi.org/10.1016/j.drugalcdep.2017.12.041

110.

Schinke

Schwinn

Hopkins

Gorroochurn

Wahlstrom

(2017). Is the legalization of marijuana associated with its use by adolescents? Substance Use and Misuse, 52(2), 256–258. https://doi.org/10.1080/10826084.2016.1223139

111.

Schlienz

N. J.

Lee

D. C.

(2018). Co-use of cannabis, tobacco, and alcohol during adolescence: Policy and regulatory implications. International Review of Psychiatry, 30(3), 226–237. https://doi.org/10.1080/09540261.2018.1465399

112.

Schmidt

L. A.

Jacobs

L. M.

Spetz

(2016). Young people’s more permissive views about marijuana: Local impact of state laws or national trend? American Journal of Public Health, 106(8), 1498–1503. https://doi.org/10.2105/AJPH.2016.303153

113.

Segura

L. E.

Mauro

C. M.

Levy

N. S.

Khauli

Philbin

M. M.

Mauro

P. M.

Martins

S. S.

(2019). Association of U.S. medical marijuana laws with nonmedical prescription opioid use and prescription opioid use disorder. JAMA Network Open, 2(7), e197216. https://doi.org/10.1001/jamanetworkopen.2019.7216

114.

Sevigny

E. L.

(2018). The effects of medical marijuana laws on cannabis-involved driving. Accident Analysis and Prevention, 118, 57–65. https://doi.org/10.1016/j.aap.2018.05.023

115.

Shah

Hayes

C. J.

Lakkad

Martin

B. C.

(2019). Impact of medical marijuana legalization on opioid use, chronic Opioid Use, and high-risk opioid use. Journal of General Internal Medicine, 34(8), 1419–1426. https://doi.org/10.1007/s11606-018-4782-2

116.

Shepard

E. M.

Blackley

P. R.

(2016). Medical marijuana and crime: Further evidence from the Western States. Journal of Drug Issues, 46(2), 122–134. https://doi.org/10.1177/0022042615623983

117.

Shi

(2017). Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug and Alcohol Dependence, 173, 144–150. https://doi.org/10.1016/j.drugalcdep.2017.01.006

118.

Shi

Liang

Bao

Wallace

M. S.

Grant

(2019). Recreational marijuana legalization and prescription opioids received by Medicaid enrollees. Drug and Alcohol Dependence, 194, 13–19. https://doi.org/10.1016/j.drugalcdep.2018.09.016

119.

Shover

C. L.

Davis

C. S.

Gordon

S. C.

Humphreys

(2019). Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America, 116(26), 12624–12626. https://doi.org/10.1073/pnas.1903434116

120.

Smith

R. A.

(2020). The effects of medical marijuana dispensaries on adverse opioid outcomes. Economic Inquiry, 58(2), 569–588. https://doi.org/10.1111/ecin.12825

121.

Stolzenberg

D’Alessio

S. J.

Dariano

(2016). The effect of medical cannabis laws on juvenile cannabis use. International Journal of Drug Policy, 27, 82–88. https://doi.org/10.1016/j.drugpo.2015.05.018

122.

Subbaraman

M. S.

Kerr

W. C.

(2020). Subgroup trends in alcohol and cannabis co-use and related harms during the rollout of recreational cannabis legalization in Washington state. International Journal of Drug Policy, 75, 102508. https://doi.org/10.1016/j.drugpo.2019.07.003

123.

Tran

N. K.

Goldstein

N. D.

Purtle

Massey

P. M.

Lankenau

S. E.

Suder

J. S.

Tabb

L. P.

(2020). The heterogeneous effect of marijuana decriminalization policy on arrest rates in Philadelphia, Pennsylvania, 2009–2018. Drug and Alcohol Dependence, 212, 108058. https://doi.org/10.1016/j.drugalcdep.2020.108058

124.

Ullman

D. F.

(2017). The effect of medical marijuana on sickness absence. Health Economics (United Kingdom), 26(10), 1322–1327. https://doi.org/10.1002/hec.3390

125.

United States Drug Enforcement Administration. (2021). Drug scheduling. https://www.dea.gov/drug-scheduling

126.

Veligati

Howdeshell

Beeler-Stinn

Lingam

Allen

P. C.

Chen

L. S.

Grucza

R. A.

(2020). Changes in alcohol and cigarette consumption in response to medical and recreational cannabis legalization: Evidence from U.S. state tax receipt data. International Journal of Drug Policy, 75, 102585. https://doi.org/10.1016/j.drugpo.2019.10.011

127.

Vigil

J. M.

Stith

S. S.

Adams

I. M.

Reeve

A. P.

(2017). Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study. PLOS ONE, 12(11), Article e0187795. https://doi.org/10.1371/journal.pone.0187795

128.

Wadsworth

Hammond

(2018). Differences in patterns of cannabis use among youth: Prevalence, perceptions of harm and driving under the influence in the USA where non-medical cannabis markets have been established, proposed and prohibited. Drug and Alcohol Review, 37(7), 903–911. https://doi.org/10.1111/dar.12842

129.

Wall

M. M.

Mauro

Hasin

D. S.

Keyes

K. M.

Cerda

Martins

S. S.

Feng

(2016). Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on Stolzenberg et al. (2015) and reanalysis of U.S. National Survey on Drug Use in Households data 2002-2011. International Journal of Drug Policy, 29, 9–13. https://doi.org/10.1016/j.drugpo.2016.01.015

130.

Wall

M. M.

Poh

Cerdá

Keyes

K. M.

Galea

Hasin

D. S.

(2011). Adolescent marijuana use from 2002 to 2008: Higher in states with medical marijuana laws, cause still unclear. Annals of Epidemiology, 21(9), 714–716. https://doi.org/10.1016/j.annepidem.2011.06.001

131.

Wallace

(2017). America’s marijuana industry headed for $24 billion by 2025. In The strain directory. https://newfrontierdata.com/news/report-americas-marijuana-industry-headed-24-billion-2025/

132.

Wang

J. B.

Ramo

D. E.

Lisha

N. E.

Cataldo

J. K.

(2016). Medical marijuana legalization and cigarette and marijuana co-use in adolescents and adults. Drug and Alcohol Dependence, 166, 32–38. https://doi.org/10.1016/j.drugalcdep.2016.06.016

133.

Wen

Hockenberry

J. M.

(2018). Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Internal Medicine, 178(5), 673–679. https://doi.org/10.1001/jamainternmed.2018.1007

134.

Wen

Hockenberry

J. M.

Cummings

J. R.

(2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. Journal of Health Economics, 42, 64–80. https://doi.org/10.1016/j.jhealeco.2015.03.007

135.

Wen

Hockenberry

J. M.

Druss

B. G.

(2019). The effect of medical marijuana laws on marijuana-related attitude and perception among U.S. adolescents and young adults. Prevention Science, 20(2), 215–223. https://doi.org/10.1007/s11121-018-0903-8

136.

Wen

Butler

J. S.

Talbert

J. C.

(2021). The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance. Health Economics (United Kingdom), 30(5), 989–1000. https://doi.org/10.1002/hec.4237

137.

Wendelboe

A. M.

Mathew

Chongsuwat

Rainwater

Wendelboe

M. A.

Wickersham

Chou

A. F.

(2019). Is there less opioid abuse in states where marijuana has been decriminalized, either for medicinal or recreational use? A Clin-IQ. Journal of Patient-centered Research and Reviews, 6(4), 267–273. https://doi.org/10.17294/2330-0698.1704

138.

Windle

S. B.

Eisenberg

M. J.

Reynier

Cabaussel

Thombs

B. D.

Grad

Ells

Sequeira

Filion

K. B.

(2021). Association between legalization of recreational cannabis and fatal motor vehicle collisions in the United States: An ecologic study. CMAJ Open, 9(1), E233–E241. https://doi.org/10.9778/cmajo.20200155

139.

Wong

K. U.

Baum

C. R.

(2019). Acute cannabis toxicity. Pediatric Emergency Care, 35(11), 799–806. https://doi.org/10.1097/PEC.0000000000001970

140.

Wong

S. W.

Buu

Lin

H. C.

(2020). State medical marijuana laws and associated marijuana use, attitudes, and perceived social norms among adolescents in the U.S. Journal of Psychoactive Drugs, 52(5), 383–392. https://doi.org/10.1080/02791072.2020.1795325

141.

Wong

S. W.

Lin

H. C.

(2019). Medical marijuana legalization and associated illicit drug use and prescription medication misuse among adolescents in the U.S. Addictive Behaviors, 90, 48–54. https://doi.org/10.1016/j.addbeh.2018.10.017

142.

Wright

A. C.

Krieg

J. M.

(2020). Getting into the weeds: Does legal marijuana access blunt academic performance in college? Economic Inquiry, 58(2), 607–623. https://doi.org/10.1111/ecin.12743

143.

Boateng

F. D.

Lang

(2020). The spillover effect of recreational marijuana legalization on crime: Evidence from neighboring states of Colorado and Washington State. Journal of Drug Issues, 50(4), 392–409. https://doi.org/10.1177/0022042620921359

144.

Chen

Yan

(2020). Marijuana legalization and historical trends in marijuana use among U.S. residents aged 12-25: Results from the 1979-2016 National Survey on Drug Use and Health. BMC Public Health, 20(1), Article 156. https://doi.org/10.1186/s12889-020-8253-4

145.

Zhu

L. T.

(2016). Trends and correlates of cannabis-involved emergency department visits: 2004 to 2011. Journal of Addiction Medicine, 10(6), 429–436. https://doi.org/10.1097/ADM.0000000000000256